Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

51.72
-3.1400-5.72%
Post-market: 51.720.00000.00%17:27 EDT
Volume:2.93M
Turnover:152.78M
Market Cap:8.18B
PE:52.79
High:53.75
Open:53.01
Low:50.35
Close:54.86
Loading ...

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

TECH Gears Up to Report Q2 Earnings: Here's What to Expect

Zacks
·
30 Jan

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
29 Jan

Baird Adjusts Bio-Techne Price Target to $86 From $84, Maintains Outperform Rating

MT Newswires Live
·
27 Jan

Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
24 Jan

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Jan

EXEL vs. TECH: Which Stock Is the Better Value Option?

Zacks
·
22 Jan

Scaleready Announces a G-Rex Grant Has Been Awarded to Brainchild Bio

THOMSON REUTERS
·
21 Jan

Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?

Simply Wall St.
·
16 Jan

RBC Capital Remains a Hold on Bio-Techne (TECH)

TIPRANKS
·
14 Jan

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
14 Jan

TECH Stock Might Rise From the Expansion of Designer Protein Portfolio

Zacks
·
13 Jan

Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
11 Jan

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
09 Jan

Bio-Techne Prevails in Second Reverse Engineering Claim by Miltenyi Biotec; Shares Up

MT Newswires Live
·
07 Jan

BRIEF-Bio-Techne Successful On Second Claim Of Reverse Engineering By Miltenyi Biotec

Reuters
·
07 Jan

Bio-Techne receives favorable ruling on second Miltenyi Biotec claim

TIPRANKS
·
07 Jan

Bio-Techne Successful on Second Claim of Reverse Engineering by Miltenyi Biotec

THOMSON REUTERS
·
07 Jan

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
07 Jan

Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
03 Jan